Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Oncotarget
|
May 2, 2019
PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models
Leah A Mitchell, Kader Yagiz, Andrew Hofacre, et al.
Journal for Immunotherapy of Cancer
|
August 30, 2024
NKG2C/<i>KLRC2</i> tumor cell expression enhances immunotherapeutic efficacy against glioblastoma
Olaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, et al.
Journal for Immunotherapy of Cancer
|
February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.
Ophthalmology
|
January 24, 2017
Concordance Between Clinical and Histopathological Diagnoses of Corneal Specimens
Christopher K H Burris, Amir A Azari, Ralph C Eagle, et al.
Molecular Cancer
|
March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Signal Transduction and Targeted Therapy
|
March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic
Iñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps
Alvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
Nature Medicine
|
February 12, 2019
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, et al.
Nature Communications
|
May 15, 2024
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
Neil H Segal, Ignacio Melero, Victor Moreno, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Oncotarget
|
May 2, 2019
PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models
Leah A Mitchell, Kader Yagiz, Andrew Hofacre, et al.
Journal for Immunotherapy of Cancer
|
August 30, 2024
NKG2C/<i>KLRC2</i> tumor cell expression enhances immunotherapeutic efficacy against glioblastoma
Olaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, et al.
Journal for Immunotherapy of Cancer
|
February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.
Ophthalmology
|
January 24, 2017
Concordance Between Clinical and Histopathological Diagnoses of Corneal Specimens
Christopher K H Burris, Amir A Azari, Ralph C Eagle, et al.
Molecular Cancer
|
March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Signal Transduction and Targeted Therapy
|
March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic
Iñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps
Alvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
Nature Medicine
|
February 12, 2019
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, et al.
Nature Communications
|
May 15, 2024
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
Neil H Segal, Ignacio Melero, Victor Moreno, et al.
Page
of 8